Why it was recalled
Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
Product description
succinylcholine 200 mg/10 mL (20 mg/mL), Syringe, Rx only, this drug was repackaged by CAPS Inc, 2200 South 43rd Avenue Pheonix, AZ, NDC 72196-6011-2.
Lot numbers, UPCs & expiration codes
Lot: 36-238812, 36-238813, 36-238814, 36-238815, 36-238816, 36-238819, Exp. 7/10/2023; 36-239281, 36-239282, 36-239284, Exp. 7/11/2023; 36-239459, 36-239460, 36-239628, 36-239629, Exp. 7/12/2023; 36-239879, 36-239880, 36-239881, Exp. 7/13/2023; 36-240272, Exp. 7/16/2023; 36-240512, 36-240513, 36-240514, 36-240515, 36-240724, Exp. 7/17/2023; 36-240991, 36-240992, 36-240993, Exp. 7/18/2023; 36-241267, 36-241269, Exp. 7/19/2023; 36-241364, 36-241366, 36-241367, 36-241368, Exp. 7/20/2023; 36-241669, 36-241670, 36-241735, Exp. 7/21/2023; 36-242079, 36-242080, 36-242081, 36-242082, 36-242083, 36-242084, 36-242085, Exp. 7/24/2023; 36-242624, 36-242627, 36-242628, 36-242629, Exp. 7/26/2023; 36-243046, 36-243047, 36-243048, 36-243049, 36-243050, 36-243051, 36-243052, Exp. 7/27/2023; 36-243824, 36-243825, 36-243826, 36-243827, 36-243828, Exp. 7/31/2023; 36-244791, Exp. 8/01/2023; 36-245798, 36-245799, 36-245800, 36-245801, 36-245802, Exp. 8/02/2023; 36-246701, Exp. 8/06/2023; 36-249000, 36-249002, Exp. 8/16/2023; 36-249509, 36-249515, Exp. 8/18/2023; 36-251029, 36-251030, 36-251031, Exp. 8/24/2023; 36-251327, 36-251328, 36-251331, Exp. 8/27/2023; 36-251825, 36-251826, 36-251827, Exp. 8/30/2023
Where it was sold
Nationwide in the USA
What to do if you have this product
- Compare the lot number and expiration date on your package with the codes above.
- Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
- If you have symptoms you think are related, contact your doctor. In an emergency call 911.
- Report side effects to FDA MedWatch at 1-800-FDA-1088.
Recall details
- Recall number
- D-0949-2023
- Classification
- Class II
- Status
- Terminated
- Recall initiated
- Jul 14, 2023
- FDA report date
- Aug 9, 2023
- Quantity
- 26,208 Syringes
- Recall type
- Voluntary: Firm initiated
- Recalling firm
- Central Admixture Pharmacy Services, Inc.
Original FDA data
Every field from FDA enforcement report D-0949-2023, exactly as published.
Show all FDA fields
- City
- Phoenix
- State
- AZ
- Status
- Terminated
- Country
- United States
- Event ID
- 92707
- Address
- 2200 S 43rd Ave
- Code information
- Lot: 36-238812, 36-238813, 36-238814, 36-238815, 36-238816, 36-238819, Exp. 7/10/2023; 36-239281, 36-239282, 36-239284, Exp. 7/11/2023; 36-239459, 36-239460, 36-239628, 36-239629, Exp. 7/12/2023; 36-239879, 36-239880, 36-239881, Exp. 7/13/2023; 36-240272, Exp. 7/16/2023; 36-240512, 36-240513, 36-240514, 36-240515, 36-240724, Exp. 7/17/2023; 36-240991, 36-240992, 36-240993, Exp. 7/18/2023; 36-241267, 36-241269, Exp. 7/19/2023; 36-241364, 36-241366, 36-241367, 36-241368, Exp. 7/20/2023; 36-241669, 36-241670, 36-241735, Exp. 7/21/2023; 36-242079, 36-242080, 36-242081, 36-242082, 36-242083, 36-242084, 36-242085, Exp. 7/24/2023; 36-242624, 36-242627, 36-242628, 36-242629, Exp. 7/26/2023; 36-243046, 36-243047, 36-243048, 36-243049, 36-243050, 36-243051, 36-243052, Exp. 7/27/2023; 36-243824, 36-243825, 36-243826, 36-243827, 36-243828, Exp. 7/31/2023; 36-244791, Exp. 8/01/2023; 36-245798, 36-245799, 36-245800, 36-245801, 36-245802, Exp. 8/02/2023; 36-246701, Exp. 8/06/2023; 36-249000, 36-249002, Exp. 8/16/2023; 36-249509, 36-249515, Exp. 8/18/2023; 36-251029, 36-251030, 36-251031, Exp. 8/24/2023; 36-251327, 36-251328, 36-251331, Exp. 8/27/2023; 36-251825, 36-251826, 36-251827, Exp. 8/30/2023
- Postal code
- 85043-3909
- Report date
- Aug 9, 2023
- Product type
- Drugs
- Recall number
- D-0949-2023
- Classification
- Class II
- Recalling firm
- Central Admixture Pharmacy Services, Inc.
- Product quantity
- 26,208 Syringes
- Termination date
- Mar 28, 2025
- Reason for recall
- Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
- Voluntary / mandated
- Voluntary: Firm initiated
- Product description
- succinylcholine 200 mg/10 mL (20 mg/mL), Syringe, Rx only, this drug was repackaged by CAPS Inc, 2200 South 43rd Avenue Pheonix, AZ, NDC 72196-6011-2.
- Distribution pattern
- Nationwide in the USA
- Recall initiation date
- Jul 14, 2023
- Initial firm notification
- Letter
- Center classification date
- Aug 1, 2023